Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

NCT00466843 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

NIH

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: Antithymocyte globulin (ATG)
DRUG: Prednisone

Sponsor

Office of Rare Diseases (ORD)

Collaborators

[object Object]